Jang Mi Han

495 total citations
20 papers, 376 citations indexed

About

Jang Mi Han is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Jang Mi Han has authored 20 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Organic Chemistry. Recurrent topics in Jang Mi Han's work include Microbial Natural Products and Biosynthesis (5 papers), Cancer Mechanisms and Therapy (4 papers) and Marine Sponges and Natural Products (4 papers). Jang Mi Han is often cited by papers focused on Microbial Natural Products and Biosynthesis (5 papers), Cancer Mechanisms and Therapy (4 papers) and Marine Sponges and Natural Products (4 papers). Jang Mi Han collaborates with scholars based in South Korea and Japan. Jang Mi Han's co-authors include Hye Jin Jung, Jae Kyung Sohng, Yue Jai Kang, Eun Kyeong Lee, Ho Jeong Kwon, Dipesh Dhakal, Tokutaro Yamaguchi, Ramesh Prasad Pandey, Tae‐Jin Oh and Tae‐Su Kim and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Jang Mi Han

20 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jang Mi Han South Korea 12 217 62 56 51 47 20 376
Celia Vargas‐De‐La‐Cruz Peru 13 183 0.8× 54 0.9× 52 0.9× 33 0.6× 37 0.8× 40 459
Ching‐Lung Liao Taiwan 11 296 1.4× 100 1.6× 52 0.9× 41 0.8× 66 1.4× 17 461
Hong-Zin Lee Taiwan 12 185 0.9× 81 1.3× 51 0.9× 34 0.7× 50 1.1× 14 381
Yiyi Ye China 11 205 0.9× 73 1.2× 45 0.8× 44 0.9× 48 1.0× 17 396
Jiahuan Yang China 11 196 0.9× 38 0.6× 55 1.0× 53 1.0× 71 1.5× 20 426
Zhiyuan Lou China 12 224 1.0× 74 1.2× 47 0.8× 22 0.4× 55 1.2× 28 467
Nidarshana Chaturvedi Parashar India 13 335 1.5× 84 1.4× 87 1.6× 45 0.9× 69 1.5× 23 552
Cheng‐Zhu Wu China 12 289 1.3× 57 0.9× 99 1.8× 37 0.7× 44 0.9× 47 446
Yeong‐In Yang South Korea 13 247 1.1× 84 1.4× 51 0.9× 98 1.9× 82 1.7× 18 615
Sang‐Mi Woo South Korea 10 208 1.0× 38 0.6× 59 1.1× 35 0.7× 58 1.2× 12 379

Countries citing papers authored by Jang Mi Han

Since Specialization
Citations

This map shows the geographic impact of Jang Mi Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jang Mi Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jang Mi Han more than expected).

Fields of papers citing papers by Jang Mi Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jang Mi Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jang Mi Han. The network helps show where Jang Mi Han may publish in the future.

Co-authorship network of co-authors of Jang Mi Han

This figure shows the co-authorship network connecting the top 25 collaborators of Jang Mi Han. A scholar is included among the top collaborators of Jang Mi Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jang Mi Han. Jang Mi Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Jang Mi, et al.. (2023). Natural Cyclophilin A Inhibitors Suppress the Growth of Cancer Stem Cells in Non-Small Cell Lung Cancer by Disrupting Crosstalk between CypA/CD147 and EGFR. International Journal of Molecular Sciences. 24(11). 9437–9437. 7 indexed citations
2.
Han, Jang Mi & Hye Jin Jung. (2022). Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells. Molecules. 27(22). 7968–7968. 9 indexed citations
3.
Han, Jang Mi & Hye Jin Jung. (2022). Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy. International Journal of Molecular Sciences. 23(16). 9341–9341. 31 indexed citations
4.
Han, Jang Mi, et al.. (2022). Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells. Cancers. 14(5). 1315–1315. 16 indexed citations
5.
Han, Jang Mi, et al.. (2021). Antiangiogenic and antitumor potential of berbamine, a natural CaMKIIγ inhibitor, against glioblastoma. Biochemical and Biophysical Research Communications. 566. 129–134. 11 indexed citations
6.
Han, Jang Mi, et al.. (2021). Ampelopsin Inhibits Cell Proliferation and Induces Apoptosis in HL60 and K562 Leukemia Cells by Downregulating AKT and NF-κB Signaling Pathways. International Journal of Molecular Sciences. 22(8). 4265–4265. 18 indexed citations
7.
Han, Jang Mi, et al.. (2021). Identification of Cyclophilin A as a Potential Anticancer Target of Novel Nargenicin A1 Analog in AGS Gastric Cancer Cells. International Journal of Molecular Sciences. 22(5). 2473–2473. 12 indexed citations
8.
Nguyen, Trang Thi Huyen, Jang Mi Han, Hye Jin Jung, et al.. (2020). Regio-specific biotransformation of alizarin to alizarin methoxide with enhanced cytotoxicity against proliferative cells. Journal of Industrial Microbiology & Biotechnology. 47(6-7). 537–542. 3 indexed citations
9.
Han, Jang Mi, et al.. (2020). Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α. International Journal of Molecular Sciences. 21(11). 4043–4043. 16 indexed citations
12.
Dhakal, Dipesh, Jang Mi Han, Ramesh Prasad Pandey, et al.. (2020). Characterization of Tailoring Steps of Nargenicin A1 Biosynthesis Reveals a Novel Analogue with Anticancer Activities. ACS Chemical Biology. 15(6). 1370–1380. 15 indexed citations
13.
Han, Jang Mi, et al.. (2020). Chloroform extract of Citrus unshiu Markovich peel induces apoptosis and inhibits stemness in HeLa human cervical cancer cells. Molecular Medicine Reports. 23(1). 9 indexed citations
15.
Nguyen, Trang Thi Huyen, Ramesh Prasad Pandey, Prakash Parajuli, et al.. (2018). Microbial Synthesis of Non-Natural Anthraquinone Glucosides Displaying Superior Antiproliferative Properties. Molecules. 23(9). 2171–2171. 10 indexed citations
16.
Jang, Jun‐Pil, Jang Mi Han, Hye Jin Jung, et al.. (2018). Anti-Angiogenesis Effects Induced by Octaminomycins A and B against HUVECs. Journal of Microbiology and Biotechnology. 28(8). 1332–1338. 5 indexed citations
18.
Yamaguchi, Tokutaro, Hye Jin Jung, Jang Mi Han, et al.. (2018). Enzymatic synthesis of novel quercetin sialyllactoside derivatives. Natural Product Research. 33(13). 1944–1952. 7 indexed citations
19.
Jung, Hye Jin, Jang Mi Han, Yonghyo Kim, et al.. (2017). Two cyclic hexapeptides from Penicillium sp. FN070315 with antiangiogenic activities. PLoS ONE. 12(9). e0184339–e0184339. 10 indexed citations
20.
Han, Jang Mi, Ho Jeong Kwon, & Hye Jin Jung. (2016). Tricin, 4′,5,7-trihydroxy-3′,5′-dimethoxyflavone, exhibits potent antiangiogenic activity in vitro. International Journal of Oncology. 49(4). 1497–1504. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026